Researchers in the Herzenberg laboratory at Stanford University have patented a method to quantify antigens during flow cytometry without the use of calibrators.
Stanford scientist has developed a computational method that extracts quantitative imaging features that reproducibly describe lesion phenotypes associated with treatment response and clinical outcomes in cancer.